Blueprint Medicines Corpo... (BPMC)
NASDAQ: BPMC
· Real-Time Price · USD
129.46
0.18 (0.14%)
At close: Jul 17, 2025, 3:59 PM
Blueprint Medicines Fail-to-Deliver
Total FTD Shares
38
Below Average
FTD / Avg. Volume
< 0.01%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 10, 2025,
Blueprint Medicines Corporation has
38
shares failed to deliver, representing 0.00%
of the average daily volume of
3,287,638
shares. Over the past year, the monthly average FTD is
5,592
shares, with the current level 99% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 10, 2025 | 129.33 | 38 | -99.80% |
| Jun 23, 2025 | 128.4 | 18.89K | +190.62% |
| May 30, 2025 | 101.35 | 6.5K | -53.18% |
| Apr 25, 2025 | 87.66 | 13.88K | +323.13% |
| Mar 05, 2025 | 89.92 | 3.28K | -96.67% |
| Feb 21, 2025 | 92.25 | 98.58K | +229155.81% |
| Jan 29, 2025 | 114.32 | 43 | -97.16% |
| Dec 30, 2024 | 86.82 | 1.51K | +25150.00% |
| Nov 12, 2024 | 96.62 | 6 | -99.83% |
| Oct 31, 2024 | 87.51 | 3.44K | +1216.86% |
| Sep 30, 2024 | 92.5 | 261 | -90.32% |
| Aug 27, 2024 | 93.14 | 2.7K | +805.03% |
| Jul 22, 2024 | 116.81 | 298 | -42.02% |
| Jun 24, 2024 | 106.1 | 514 | -46.23% |
| May 31, 2024 | 105.56 | 956 | -94.25% |
| Apr 30, 2024 | 91.34 | 16.62K | +30121.82% |
| Mar 27, 2024 | 94.79 | 55 | +323.08% |
| Feb 27, 2024 | 99.79 | 13 | -95.08% |
| Jan 30, 2024 | 83.52 | 264 | +380.00% |
| Dec 20, 2023 | 84.12 | 55 | -98.50% |
| Nov 28, 2023 | 68.37 | 3.66K | +191.32% |
| Oct 30, 2023 | 54.34 | 1.26K | +131.31% |
| Sep 28, 2023 | 51.07 | 543 | -10.25% |
| Aug 10, 2023 | 49.4 | 605 | +119.20% |
| Jul 31, 2023 | 66 | 276 | -40.65% |
| Jun 29, 2023 | 66.37 | 465 | -41.88% |
| May 26, 2023 | 57.75 | 800 | +0.50% |
| Apr 28, 2023 | 51.05 | 796 | +8744.44% |
| Mar 28, 2023 | 42.57 | 9 | -91.35% |
| Feb 24, 2023 | 37.97 | 104 | -76.31% |
| Jan 31, 2023 | 46.74 | 439 | n/a |